Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
Fatal overdoses from the last six months already exceeded the count for 2015
The 50-year-old Mass. man received 4 doses from firefighters, 3 from paramedics
A single prehospital treatment protocol for respiratory distress from asthma or COPD is reasonable
Good samaritans discover couple who had overdosed at the wheel and called for EMS
The ambulance service features new banners and a social media campaign in response to the state’s opioid epidemic
Public health officials are increasingly looking at naloxone as an antidote to the state’s increasing overdose death rate
After a Mich. woman was T-boned by a semi, EMS crews were hit while protecting the scene
Paramedic chiefs and EMS leaders can ensure pediatric patients receive the correct care with right preparation, equipment and training
Akron police suspect fentanyl-laced heroin as the cause of 17 overdoses in one day
The cap is being raised from 100 patients per doctor to 275
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.